Trademark: 97524032
Word
RESPIRA THERAPEUTICS
Status Date
Wednesday, February 21, 2024
Filing Date
Thursday, July 28, 2022
Published for Opposition
Tuesday, June 27, 2023
5 Portable dry powder inhaler provided filled used for the administration to patients via oral inhalation of therapeutic or diagnostic agents in the form of dry powder aerosols for the treatment or prophylaxis of local lung and systemic diseases
10 Portable dry powder inhaler provided empty used for the administration to patients via oral inhalation of therapeutic or diagnostic agents in the form of dry powder aerosols for the treatment or prophylaxis of local lung and systemic diseases, sold as a unit with the therapeutic or diagnostic agents in the form of dry powder aerosols
42 Medical research services; Research and development of new products and pharmaceutical preparations in the field of medicine; scientific, medical and pharmaceutical research and development; drug discovery services; providing medical and scientific research information in the field of medicine and pharmaceuticals; scientific investigations for medical purposes
The English translation of the word "RESPIRA" in the mark is "Breathe, relax, exude or obviate."
"THERAPEUTICS"
Feb 22, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 21, 2024
Sou Extension 1 Granted
Feb 21, 2024
Sou Extension 1 Filed
Feb 21, 2024
Sou Teas Extension Received
Aug 22, 2023
Noa E-Mailed - Sou Required From Applicant
Jun 27, 2023
Official Gazette Publication Confirmation E-Mailed
Jun 27, 2023
Published For Opposition
Jun 7, 2023
Notification Of Notice Of Publication E-Mailed
May 19, 2023
Approved For Pub - Principal Register
May 19, 2023
Examiner's Amendment Entered
May 19, 2023
Notification Of Examiners Amendment E-Mailed
May 19, 2023
Examiners Amendment E-Mailed
May 19, 2023
Examiners Amendment -Written
May 15, 2023
Assigned To Examiner
Aug 19, 2022
New Application Office Supplied Data Entered
Aug 1, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
